Cite
HARVARD Citation
Boisteau, E. et al. (2022). SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer. Digestive and liver disease. 54 (6), pp. 747-754. [Online].